Riscos e benefícios associados à continuação de anti-TNF após 24 semanas de gestação na doença inflamatória intestinal.

Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Anti-TNF continuation after 24 weeks of pregnancy beneficial to persons with IBD, does not affect neonatal outcomes – American College of Physicians

Comentário: Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial – HealthDay

Comentário no Twitter

10 year trial found continuation of #AntiTNF treatment after 24 weeks of pregnancy appears beneficial for #IBD activity and prematurity, not affecting neonatal outcomes and serious infections in the offspring. @EPIPHARE https://t.co/YuytSQqDsE pic.twitter.com/CRGN80K93A

— Annals of Int Med (@AnnalsofIM) September 27, 2022